These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 25927625)

  • 1. Comparative studies on the inhibitory activities of selected benzoic acid derivatives against secretory phospholipase A2, a key enzyme involved in the inflammatory pathway.
    Dileep KV; Remya C; Cerezo J; Fassihi A; Pérez-Sánchez H; Sadasivan C
    Mol Biosyst; 2015 Jul; 11(7):1973-9. PubMed ID: 25927625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting human secretory phospholipase A2 with designed peptide inhibitors for inflammatory therapy.
    Wang P; Li Y; Shao Q; Zhou W; Wang K
    J Drug Target; 2015 Feb; 23(2):140-6. PubMed ID: 25237841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of new secretory phospholipase A2-inhibitory indole containing isoxazole derivatives as anti-inflammatory and anticancer agents.
    Pedada SR; Yarla NS; Tambade PJ; Dhananjaya BL; Bishayee A; Arunasree KM; Philip GH; Dharmapuri G; Aliev G; Putta S; Rangaiah G
    Eur J Med Chem; 2016 Apr; 112():289-297. PubMed ID: 26907155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel secretory phospholipase A2 inhibitors using virtual screen.
    Qiu S; Chen F; Liu Y; Lai L
    Chem Biol Drug Des; 2014 Aug; 84(2):216-22. PubMed ID: 24612767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Rhamnetin as an Inhibitor of the Pharmacological Effect of Secretory Phospholipase A2.
    Novo Belchor M; Hessel Gaeta H; Fabri Bittencourt Rodrigues C; Ramos da Cruz Costa C; de Oliveira Toyama D; Domingues Passero LF; Dalastra Laurenti M; Hikari Toyama M
    Molecules; 2017 Aug; 22(9):. PubMed ID: 28858248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtual analysis of structurally diverse synthetic analogs as inhibitors of snake venom secretory phospholipase A2.
    Sivaramakrishnan V; Ilamathi M; Ghosh KS; Sathish S; Gowda TV; Vishwanath BS; Rangappa KS; Dhananjaya BL
    J Mol Recognit; 2016 Jan; 29(1):22-32. PubMed ID: 26218369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Inhibitory Potential of Casuarictin, an Ellagitannin Isolated from White Mangrove (
    Rodrigues CFB; Ferreira MJP; Belchor MN; Costa CRC; Novaes DP; Dos Santos Junior AB; Tamayose CI; Pinho MVT; de Oliveira MA; Toyama MH
    Mar Drugs; 2019 Jul; 17(7):. PubMed ID: 31288445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of inhibition of human secretory phospholipase A2 by flavonoids: rationale for lead design.
    Lättig J; Böhl M; Fischer P; Tischer S; Tietböhl C; Menschikowski M; Gutzeit HO; Metz P; Pisabarro MT
    J Comput Aided Mol Des; 2007 Aug; 21(8):473-83. PubMed ID: 17701137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane Allostery and Unique Hydrophobic Sites Promote Enzyme Substrate Specificity.
    Mouchlis VD; Chen Y; McCammon JA; Dennis EA
    J Am Chem Soc; 2018 Mar; 140(9):3285-3291. PubMed ID: 29342349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological evaluation and docking studies of α,β-unsaturated carbonyl based synthetic compounds as inhibitors of secretory phospholipase A₂, cyclooxygenases, lipoxygenase and proinflammatory cytokines.
    Bukhari SN; Lauro G; Jantan I; Bifulco G; Amjad MW
    Bioorg Med Chem; 2014 Aug; 22(15):4151-61. PubMed ID: 24938495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel peptide inhibitors of human secretory phospholipase A2 with antiinflammatory activity: solution structure and molecular modeling.
    Thwin MM; Satyanarayanajois SD; Nagarajarao LM; Sato K; Arjunan P; Ramapatna SL; Kumar PV; Gopalakrishnakone P
    J Med Chem; 2007 Nov; 50(24):5938-50. PubMed ID: 17973469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quercetin as an inhibitor of snake venom secretory phospholipase A2.
    Cotrim CA; de Oliveira SC; Diz Filho EB; Fonseca FV; Baldissera L; Antunes E; Ximenes RM; Monteiro HS; Rabello MM; Hernandes MZ; de Oliveira Toyama D; Toyama MH
    Chem Biol Interact; 2011 Jan; 189(1-2):9-16. PubMed ID: 21056032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling of the additional inhibitor site located in secretory phospholipase A(2).
    Ompraba G; Velmurugan D; Louis PA; Rafi ZA
    J Biomol Struct Dyn; 2010 Feb; 27(4):489-500. PubMed ID: 19916570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of selected indole derivatives with phospholipase A₂: in silico and in vitro analysis.
    Dileep KV; Remya C; Tintu I; Haridas M; Sadasivan C
    J Mol Model; 2013 Apr; 19(4):1811-7. PubMed ID: 23315198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based grafting, mutation, and optimization of peptide inhibitors to fit in the active pocket of human secreted phospholipase A2: find new use of old Peptide agents with anti-inflammatory activity.
    Zhan C; Li S; Zhong Q; Zhou D
    Chem Biol Drug Des; 2015 Apr; 85(4):418-26. PubMed ID: 25187416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioaffinity Fishing Procedure Using Secretory Phospholipase A2 for Screening for Bioactive Components: Modulation of Pharmacological Effect Induced by sPLA2 from
    Dos Santos Junior AB; Tamayose CI; Ferreira MJP; Belchor MN; Costa CRC; de Oliveira MA; Toyama MH
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31936688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chlorogenic acid (5-Caffeoylquinic Acid) isolated from Baccharis oxyodonta on the structure and pharmacological activities of secretory phospholipase A2 from Crotalus durissus terrificus.
    Toyama DO; Ferreira MJ; Romoff P; Fávero OA; Gaeta HH; Toyama MH
    Biomed Res Int; 2014; 2014():726585. PubMed ID: 25258715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Silico and In Vitro Study of the Bromelain-Phytochemical Complex Inhibition of Phospholipase A2 (Pla2).
    Mohamed Tap F; Abd Majid FA; Ismail HF; Wong TS; Shameli K; Miyake M; Ahmad Khairudin NB
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29351216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural aspects and activation mechanism of human secretory group IIA phospholipase.
    Manukyan AK
    Eur Biophys J; 2020 Sep; 49(6):511-531. PubMed ID: 32852622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical modification of ascorbic acid and evaluation of its lipophilic derivatives as inhibitors of secretory phospholipase A(2) with anti-inflammatory activity.
    Mohamed R; Dharmappa KK; Tarannum S; Jameel NM; Kannum SA; Ashrafulla HS; Rai L; Souza CJ; Shekhar MA; Vishwanath BS
    Mol Cell Biochem; 2010 Dec; 345(1-2):69-76. PubMed ID: 20730622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.